165 related articles for article (PubMed ID: 36800896)
1. Association Between Time to Antiretroviral Therapy and Loss to Care Among Newly Diagnosed Rwandan People Living with Human Immunodeficiency Virus.
Murenzi G; Kim HY; Shi Q; Muhoza B; Munyaneza A; Kubwimana G; Remera E; Nsanzimana S; Yotebieng M; Nash D; Anastos K; Ross J
AIDS Res Hum Retroviruses; 2023 May; 39(5):253-261. PubMed ID: 36800896
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of same-day antiretroviral therapy initiation in retention outcomes among people living with human immunodeficiency virus in Ethiopia: empirical evidence.
Ahmed I; Demissie M; Worku A; Gugsa S; Berhane Y
BMC Public Health; 2020 Nov; 20(1):1802. PubMed ID: 33243185
[TBL] [Abstract][Full Text] [Related]
3. Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa.
Ross J; Brazier E; Fatti G; Jaquet A; Tanon A; Haas AD; Diero L; Castelnuovo B; Yiannoutsos CT; Nash D; Anastos KM; Yotebieng M
Clin Infect Dis; 2023 Jan; 76(1):39-47. PubMed ID: 36097726
[TBL] [Abstract][Full Text] [Related]
4. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
[TBL] [Abstract][Full Text] [Related]
5. How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study.
Ross J; Ingabire C; Umwiza F; Gasana J; Munyaneza A; Murenzi G; Nsanzimana S; Remera E; Akiyama MJ; Anastos KM; Adedimeji A
PLoS One; 2021; 16(5):e0251645. PubMed ID: 33984044
[TBL] [Abstract][Full Text] [Related]
6. Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.
Nsanzimana S; Remera E; Kanters S; Forrest JI; Ford N; Condo J; Binagwaho A; Bucher H; Thorlund K; Vitoria M; Mills EJ
Lancet HIV; 2015 Sep; 2(9):e376-84. PubMed ID: 26423551
[TBL] [Abstract][Full Text] [Related]
7. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
8. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
9. The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.
Glass TR; Günthard HF; Calmy A; Bernasconi E; Scherrer AU; Battegay M; Steffen A; Böni J; Yerly S; Klimkait T; Cavassini M; Furrer H
Clin Infect Dis; 2021 Apr; 72(8):1413-1421. PubMed ID: 32157270
[TBL] [Abstract][Full Text] [Related]
10. Reducing time to differentiated service delivery for newly-diagnosed people living with HIV in Kigali, Rwanda: a pilot, unblinded, randomized controlled trial.
Ross J; Anastos K; Hill S; Remera E; Rwibasira GN; Ingabire C; Umwiza F; Munyaneza A; Muhoza B; Zhang C; Nash D; Yotebieng M; Murenzi G
BMC Health Serv Res; 2024 Apr; 24(1):555. PubMed ID: 38693537
[TBL] [Abstract][Full Text] [Related]
11. Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya.
Teasdale CA; Hernandez C; Zerbe A; Chege D; Hawken M; El-Sadr WM
BMC Infect Dis; 2020 Jul; 20(1):508. PubMed ID: 32664854
[TBL] [Abstract][Full Text] [Related]
12. Better Outcomes Among HIV-Infected Rwandan Children 18-60 Months of Age After the Implementation of "Treat All".
Arpadi S; Lamb M; Nzeyimana IN; Vandebriel G; Anyalechi G; Wong M; Smith R; Rivadeneira ED; Kayirangwa E; Malamba SS; Musoni C; Koumans EH; Braaten M; Nsanzimana S
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):e74-e83. PubMed ID: 30422899
[TBL] [Abstract][Full Text] [Related]
13. Early outcomes after implementation of treat all in Rwanda: an interrupted time series study.
Ross J; Sinayobye JD; Yotebieng M; Hoover DR; Shi Q; Ribakare M; Remera E; Bachhuber MA; Murenzi G; Sugira V; Nash D; Anastos K;
J Int AIDS Soc; 2019 Apr; 22(4):e25279. PubMed ID: 30993854
[TBL] [Abstract][Full Text] [Related]
14. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
Tymejczyk O; Brazier E; Yiannoutsos CT; Vinikoor M; van Lettow M; Nalugoda F; Urassa M; Sinayobye JD; Rebeiro PF; Wools-Kaloustian K; Davies MA; Zaniewski E; Anderegg N; Liu G; Ford N; Nash D;
PLoS Med; 2019 Jun; 16(6):e1002822. PubMed ID: 31181056
[TBL] [Abstract][Full Text] [Related]
15. Effect of the "universal test and treat" policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda.
Mugenyi L; Hansen CH; Mayaud P; Seeley J; Newton R; Nanfuka M; Abaasa A; Mugisha K; Etukoit M; Kaleebu P; Ruzagira E
Front Public Health; 2023; 11():1187274. PubMed ID: 37361157
[TBL] [Abstract][Full Text] [Related]
16. HIV care continuum in Rwanda: a cross-sectional analysis of the national programme.
Nsanzimana S; Kanters S; Remera E; Forrest JI; Binagwaho A; Condo J; Mills EJ
Lancet HIV; 2015 May; 2(5):e208-15. PubMed ID: 26423003
[TBL] [Abstract][Full Text] [Related]
17. Trends and factors associated with initiation of HIV treatment among PLHIV in Jamaica, 2015-2019.
Cushnie A; Reintjes R; Figueroa JP; Artama M
PLoS One; 2023; 18(5):e0265468. PubMed ID: 37235603
[TBL] [Abstract][Full Text] [Related]
18. Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study.
Nsanzimana S; Semakula M; Ndahindwa V; Remera E; Sebuhoro D; Uwizihiwe JP; Ford N; Tanner M; Kanters S; Mills EJ; Bucher HC
BMC Infect Dis; 2019 Apr; 19(1):312. PubMed ID: 30953449
[TBL] [Abstract][Full Text] [Related]
19. A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
Maskew M; Brennan AT; Fox MP; Vezi L; Venter WDF; Ehrenkranz P; Rosen S
PLoS Med; 2020 Aug; 17(8):e1003226. PubMed ID: 32853271
[TBL] [Abstract][Full Text] [Related]
20. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
